Zynex monitoring solutions announces first enrollment in a blood loss detection clinical trial for its cm-1600 monitoring system

Englewood, colo. , sept. 21, 2022 /prnewswire/ -- zynex, inc. (nasdaq: zyxi), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation and patient monitoring, today announced it has begun enrollments in a large-scale blood loss detection clinical trial with its second-generation monitoring system, the cm-1600.
ZYXI Ratings Summary
ZYXI Quant Ranking